NCT00764777

Efficacy Study of Iliac Stents to Treat TASC A-B-C-D Iliac Artery Lesions

Physician Initiated Multi-center Belgian-Italian-Dutch Trial Investigating Abbott Vascular Iliac Stents in the Treatment of TASC A, B, C & D Iliac Lesions

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 325 (actual)
• Sponsor: Flanders Medical Research Program · Network
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The BRAVISSIMO trial wants to investigate in a controlled setting, the long-term (up to 24 months) outcome of the self-expanding nitinol Absolute Pro (Abbott Vascular) and the balloon-expandable Omnilink Elite (Abbott Vascular) stent in TASC A\&B and TASC C\&D iliac lesions. A separate analysis of both patient populations will be performed and listed.

Conditions

• Peripheral Vascular Disease
• Intermittent Claudication
• Critical Limb Ischemia

Interventions

Type	Name	Description
DEVICE	iliac stenting	Absolute Pro (Abbott Vascular) or Omnilink Elite (Abbott Vascular) stents

Timeline

• Start date: 2008-12-01
• Primary completion: 2010-09-01
• Completion: 2012-12-01
• First posted: 2008-10-02
• Last updated: 2013-01-25

Locations

5 sites across 1 country: Belgium